Seattle, Wash. - Radiant Research Inc., a comprehensive clinical research company that provides phase 0-IV study conduct and drug development services to the biopharmaceutical industry, today announced it will present at the Institute for International Research's conference on Early Human Data on January 20, 2006 at The Fairmont Hotel in San Francisco, California.

Dr. Brian Horger will discuss the FDA's Exploratory Investigational New Drug (IND) Guidance for early human testing. Interested parties can register for the conference at http://www.iirusa.com/earlyhumandata.

                                                             ###

About Radiant Research
Based near Seattle, Washington, Radiant Research (radiantresearch.com) is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant is comprised of more than 30 wholly-owned premier clinical research centers nationwide, employing over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.

Contact:
Michael K. Lester Chief Executive Officer RADIANT RESEARCH (425) 468-6200	Pamela M. Spaniac Chief Financial Officer RADIANT RESEARCH (425) 468-6200